HCA Healthcare (HCA) to Release Quarterly Earnings on Tuesday

HCA Healthcare (NYSE:HCA - Get Free Report) will likely be announcing its Q2 2025 earnings results before the market opens on Tuesday, July 22nd. Analysts expect the company to announce earnings of $6.20 per share and revenue of $18.49 billion for the quarter. HCA Healthcare has set its FY 2025 guidance at 24.050-25.850 EPS.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. During the same quarter in the previous year, the business posted $5.36 EPS. The business's revenue for the quarter was up 5.7% on a year-over-year basis. On average, analysts expect HCA Healthcare to post $25 EPS for the current fiscal year and $28 EPS for the next fiscal year.

HCA Healthcare Stock Down 2.3%

HCA stock traded down $8.76 during midday trading on Tuesday, reaching $371.69. The company had a trading volume of 1,304,359 shares, compared to its average volume of 1,457,608. HCA Healthcare has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $89.42 billion, a P/E ratio of 16.53, a PEG ratio of 1.30 and a beta of 1.47. The company has a 50 day moving average of $375.75 and a two-hundred day moving average of $342.80.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were given a $0.72 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.77%. HCA Healthcare's payout ratio is 12.81%.

Insider Activity at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HCA Healthcare

An institutional investor recently raised its position in HCA Healthcare stock. NewEdge Advisors LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 3,859 shares of the company's stock after purchasing an additional 409 shares during the period. NewEdge Advisors LLC's holdings in HCA Healthcare were worth $1,334,000 as of its most recent filing with the SEC. 62.73% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of recent research reports. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Robert W. Baird restated a "neutral" rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Guggenheim started coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating for the company. Finally, Barclays set a $416.00 target price on shares of HCA Healthcare and gave the company an "overweight" rating in a research note on Monday, June 2nd. Seven equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $395.71.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.